-
1Academic Journal
المؤلفون: Diez, P, Hanna, GG, Aitken, KL, van As, N, Carver, A, Colaco, RJ, Conibear, J, Dunne, EM, Eaton, DJ, Franks, KN, Good, JS, Harrow, S, Hatfield, P, Hawkins, MA, Jain, S, McDonald, F, Patel, R, Rackley, T, Sanghera, P, Tree, A, Murray, L
المصدر: Clinical Oncology , 34 (5) pp. 288-300. (2022)
مصطلحات موضوعية: Constraints, OAR, SABR, SBRT, normal tissue, stereotactic radiotherapy
وصف الملف: text
Relation: https://discovery.ucl.ac.uk/id/eprint/10145084/1/Hawkins_UK%20SABR%20consensus%20constraints%20171221%20manuscript%20only%20rev1%20170122%20CLEAN%20full.pdf; https://discovery.ucl.ac.uk/id/eprint/10145084/
-
2Academic Journal
المؤلفون: Tarn, DM, Guzmán, JR, Good, JS, Wenger, NS, Coulter, ID, Paterniti, DA
المصدر: Journal of General Internal Medicine. 29(9)
مصطلحات موضوعية: General & Internal Medicine, Clinical Sciences
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/5g0439sd
-
3Academic Journal
المؤلفون: Harrington, KJ, Bhide, SA, Forster, MD, Good, JS, Gunn, L, Kong, A, Melcher, AA, Metcalf, R, Nenclares, P, Newbold, KL, Nutting, CM, Prestwich, R, Sacco, JJ, Soliman, H, Wong, KH
المصدر: Clinical Oncology , 32 (8) pp. 490-492. (2020)
وصف الملف: text
Relation: https://discovery.ucl.ac.uk/id/eprint/10114110/1/main%20%287%29.pdf; https://discovery.ucl.ac.uk/id/eprint/10114110/
-
4Academic Journal
المصدر: Social Science & Medicine. Feb2005, Vol. 60 Issue 4, p893-910. 18p.
-
5Academic Journal
المؤلفون: Zandberg, Dan P., Algazi, Alain P., Jimeno, Antonio, Good, James S., Fayette, Jérôme, Bouganim, Nathaniel, Braña Garcia, Irene
المساهمون: Institut Català de la Salut, Zandberg DP University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA. Algazi AP University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Jimeno A Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA. Good JS Institute of Head and Neck Studies and Education, Queen Elizabeth Hospital, Birmingham, UK. Fayette J Clinical Oncology, Cancer Center Centre Léon Bérard, University of Lyon, Lyon, France. Bouganim N Department of Oncology, McGill University Health Centre, Montreal, QC, Canada. Braña I Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Cap - Càncer, Coll - Càncer, Anticossos monoclonals, DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal, DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Squamous Cell Carcinoma of Head and Neck, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas::carcinoma de células escamosas de cabeza y cuello
وصف الملف: application/pdf
Relation: European Journal of Cancer;107; https://www.ejcancer.com/article/S0959-8049(18)31513-2/fulltext; Zandberg DP, Algazi AP, Jimeno A, Good JS, Fayette J, Bouganim N, et al. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. Eur J Cancer. 2019 Jan;107:142–52.; https://hdl.handle.net/11351/5761; 000454908700018
-
6
المؤلفون: Zandberg, D. P., Algazi, A. P., Jimeno, A., Good, J. S., Fayette, J., Bouganim, N., Ready, N. E., Clement, P. M., Even, C., Jang, R. W., Wong, S., Keilholz, Ulrich, Gilbert, J., Fenton, M., Braña, Irene, Henry, S., Remenar, E., Papai, Z., Siu, L. L., Jarkowski, A., Armstrong, Jon M., Asubonteng, K., Fan, J., Melillo, G., Mesía, R., Universitat Autònoma de Barcelona
المساهمون: Institut Català de la Salut, [Zandberg DP] University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA. [Algazi AP] University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. [Jimeno A] Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA. [Good JS] Institute of Head and Neck Studies and Education, Queen Elizabeth Hospital, Birmingham, UK. [Fayette J] Clinical Oncology, Cancer Center Centre Léon Bérard, University of Lyon, Lyon, France. [Bouganim N] Department of Oncology, McGill University Health Centre, Montreal, QC, Canada. [Braña I] Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, UCL - (MGD) Service d'oncologie médicale, UCL - SSS/IREC/MONT - Pôle Mont Godinne
المصدر: Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
European journal of cancer, Vol. 107, p. 142-152 (2019)مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Survival rate, Durvalumab, medicine.medical_treatment, MULTICENTER, Phases of clinical research, Cap - Càncer, neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas::carcinoma de células escamosas de cabeza y cuello [ENFERMEDADES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Gastroenterology, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Neoplasms::Neoplasms by Site::Head and Neck Neoplasms [DISEASES], Quimioteràpia, Monoclonal, Head and neck cancer, Càncer de cap, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales [COMPUESTOS QUÍMICOS Y DROGAS], AGENT, Aged, 80 and over, Antibodies, Monoclonal, Middle Aged, Prognosis, OPEN-LABEL, CANCER, CETUXIMAB, METHOTREXATE, Survival Rate, Oncology, Head and Neck Neoplasms, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Female, Immunotherapy, Life Sciences & Biomedicine, Adult, medicine.medical_specialty, HPV, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antibodies, GEFITINIB, Head cancer, Coll - Càncer, Young Adult, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Chemotherapy, neoplasias::neoplasias por localización::neoplasias de cabeza y cuello [ENFERMEDADES], Adverse effect, PEMBROLIZUMAB, Aged, Salvage Therapy, Science & Technology, Recurrent or metastatic, Squamous Cell Carcinoma of Head and Neck, business.industry, International Agencies, medicine.disease, Neck cancer, Head and neck squamous-cell carcinoma, Càncer de coll, 030104 developmental biology, Neoplasms::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Squamous Cell Carcinoma of Head and Neck [DISEASES], Neoplasm Recurrence, Local, business, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal [CHEMICALS AND DRUGS], Anticossos monoclonals, Follow-Up Studies
وصف الملف: application/pdf; Print-Electronic